Did you know?

ChinaBio^® Group is a consulting and advisory firm helping life science companies and investors achieve success in China. ChinaBio works with U.S., European and APAC companies and investors seeking partnerships, acquisitions, novel technologies and funding in China.

Learn more >>

Free Newsletter

Have the latest stories on China's life science industry delivered to your inbox daily or weekly - free!

See preview >>

Free Report

State of China Life Science 2022

Free Content

Week in Review

In My Opinion

Free Articles

Subscriber Content

Mindray Signs Agreement to Use Masimo's Pulse Oximetry Technology in Monitors

publication date: May 14, 2019

Shenzhen Mindray signed a purchase and license agreement allowing it to use Masimo's technology for noninvasive, continuous measurement of oxygen saturation, pulse rate, and perfusion index in its monitoring devices. The SET® Measure-through Motion and Low Perfusion™ pulse oximetry will be available in Mindray devices sold in some European countries, the Middle East, Asia-Pacific (excluding China), including Australia and India. The new pact expands an earlier agreement between the two companies. Masimo is headquartered in Switzerland. More details....

Stock Symbols: (SHZ: 300760) (NSDQ: MASI)

Share this with colleagues:

This article is available for purchase - please click here for details.

Sorry this page is available to subscribers only.
If you're not a subscriber why not subscribe today?

If you are already a subscriber, please login.

If you believe you should have received this message in error, please contact us.

To gain access to the members only content click here to subscribe.

You will be given immediate access to premium content on the site.

Click here to join.